College of Dentistry
Oraceuticals produces natural products related to anti-microbial and anti-inflammation markets in the oral health industry. Oral infections that cause dental caries have a substantial impact on the growth and development of young people. And chronic oral infections that cause periodontitis result in oral inflammation which can contribute to existing risk factors for cardiovascular disease, diabetes, and preterm/low-birthweight infants. The company is founded on research conducted at the University of Kentucky by Jeffery Ebersole and Brad Huang, recognized experts in the field of oral health research. Oraceuticals left UK in October 2012.